Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery Cover

.blurhash-client-img { display: none !important; }

Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery

Radiology and Oncology

Volume 60 (2026): Issue 1 (March 2026)

By: Tomaz Jurca, Lucka Boltezar, Miha Orazem, Kristina Fujs Komlos, Katka Pohar, Sara Jevnikar, Mario Poljak, Denis Mlakar Mastnak, Nada Rotovnik Kozjek, Bor Vratanar, Janja Ocvirk and Alojz Ihan

Open Access

|Mar 2026

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/raon-2026-0014 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 76 - 85

Submitted on: Feb 16, 2026

|

Accepted on: Feb 24, 2026

|

Published on: Mar 24, 2026

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

COVID-19 vaccines,

humoral immunity,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2026 Tomaz Jurca, Lucka Boltezar, Miha Orazem, Kristina Fujs Komlos, Katka Pohar, Sara Jevnikar, Mario Poljak, Denis Mlakar Mastnak, Nada Rotovnik Kozjek, Bor Vratanar, Janja Ocvirk, Alojz Ihan, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous article Volume 60 (2026): Issue 1 (March 2026)Next article